Breakthrough Stocks of the Day: GreenMan Technologies, Freddie Mac, and Generex Biotechnology Corp
GreenMan Technologies, Inc., a leader in alternative energy and renewable fuels, has been named the "Resistance-Breaker of the day" by Breakthrough Stocks, a website that profiles stocks of interest. The company's American Power Group, Inc. subsidiary has received an order from Mutual Redevelopment Houses, Inc. for the conversion of approximately 33% of the stationary diesel engines used by their Penn South cooperative housing facility in New York City. The initial order is valued at approximately $264,000 and is expected to be completed by the end of November 2010. MRH has verbally indicated that upon the successful completion of this initial order, they intend to place an order to convert the remaining stationary diesel engines over a six to nine month period, with an estimated value of approximately $300,000.
Freddie Mac, a leader in the residential mortgage market, has named Jerry Weiss to the newly created position of chief administrative officer (CAO). Weiss will continue to serve as the company's chief compliance officer and oversee the Compliance, Economics and Strategy, Regulatory Affairs and Mission divisions. As CAO, he will also manage two additional functions - External Relations and Human Resources.
Meanwhile, Generex Biotechnology Corporation, a leader in drug delivery for metabolic diseases, has created a scientific advisory board to further its drug development programs in oncology and metabolic diseases. The company has been in late stage talks with a number of key industry leaders in the pharmaceutical and biotechnology industry to assist in positioning its drug delivery and vaccine programs for commercialization.
Key Takeaways:
- GreenMan Technologies' American Power Group, Inc. subsidiary has received an order from Mutual Redevelopment Houses, Inc. for the conversion of approximately 33% of the stationary diesel engines used by their Penn South cooperative housing facility in New York City, valued at approximately $264,000.
- Freddie Mac has named Jerry Weiss to the newly created position of chief administrative officer (CAO), who will oversee the Compliance, Economics and Strategy, Regulatory Affairs and Mission divisions, as well as External Relations and Human Resources.
- Generex Biotechnology Corporation has created a scientific advisory board to further its drug development programs in oncology and metabolic diseases, with a focus on positioning its drug delivery and vaccine programs for commercialization.
- The three companies are innovators in their respective fields, with GreenMan Technologies leading in alternative energy and renewable fuels, Freddie Mac in the residential mortgage market, and Generex Biotechnology Corporation in drug delivery for metabolic diseases.
- The formation of the scientific advisory board by Generex Biotechnology Corporation reflects a growing trend in the biotechnology industry to leverage expert guidance and input to drive innovation and commercialization.
- The appointment of Jerry Weiss as CAO at Freddie Mac underscores the company's commitment to effective management and regulatory compliance.
Statistics:
- The initial order from Mutual Redevelopment Houses, Inc. for GreenMan Technologies' American Power Group, Inc. subsidiary is valued at approximately $264,000 and is expected to be completed by the end of November 2010.
- The estimated value of the potential follow-on order from MRH for the remaining stationary diesel engines is approximately $300,000.
- Freddie Mac has supported communities across the nation by providing mortgage capital to lenders, making home possible for one in six homebuyers and more than five million renters over the years.
- Generex Biotechnology Corporation has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity, with no deposit in the lungs.
Sources:
- Breakthrough Stocks (www.breakthroughstocks.net)
- GreenMan Technologies, Inc. (www.americanpowergroupinc.com)
- Freddie Mac (www.FreddieMac.com)
- Generex Biotechnology Corporation (www.generex.com)
- M2 PressWIRE (http://www.presswire.net)